Clinical Trial Update: HPV Vaccination in Special Risk Groups: 5 Year Follow-up

View source ↗

Summary

A 5-year follow-up of HPV vaccination in special risk groups was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Rheumatic Diseases

Drugs mentioned

• HPV vaccine

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: PRD (Paediatric Rheumatological Disease), IBD (Inflammatory Bowel Disease) | Status: TERMINATED | Results posted: 2017-06-15